CP and gastric cancer: In patients with gastric cancer at stages I and II of the disease, there is an increase in the concentration of the end products of lipid peroxidation—MDA, as well as an increase in the activity of such enzymes of antioxidant protection as SOD, GST, GPO, and CP, and a decrease in the activity of CAT.